A detailed history of Hood River Capital Management LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Hood River Capital Management LLC holds 214,290 shares of HAE stock, worth $13.5 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
214,290
Previous 200,580 6.84%
Holding current value
$13.5 Million
Previous $16.1 Million 3.79%
% of portfolio
0.29%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$71.16 - $93.38 $975,603 - $1.28 Million
13,710 Added 6.84%
214,290 $16.7 Million
Q3 2024

Nov 14, 2024

SELL
$72.45 - $91.58 $3.22 Million - $4.08 Million
-44,510 Reduced 18.16%
200,580 $16.1 Million
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $17.9 Million - $21.4 Million
220,090 Added 880.36%
245,090 $20.3 Million
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $1.78 Million - $2.13 Million
25,000 New
25,000 $2.13 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.23B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Hood River Capital Management LLC Portfolio

Follow Hood River Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.